Results 51 to 60 of about 8,911,089 (208)

Procedural Volume and Outcomes in Lower‐Extremity Peripheral Vascular Interventions: Insights From the NCDR Peripheral Vascular Intervention Registry

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Lower‐extremity peripheral vascular interventions (PVIs) are increasingly used for treatment of peripheral artery disease. However, the relationship between hospital and operator PVI volume with in‐hospital major adverse limb events (MALEs ...
Zainali Chunawala, Arman Qamar, Kevin Kennedy, Neil Keshvani, Ambarish Pandey, Dharam J. Kumbhani, Cheong Jun Lee, Gregory Mishkel, Eric Secemsky, Deepak L. Bhatt   +9 more
doaj   +1 more source

Discrimination of model in predicting major adverse cardiovascular events (MACE).

, 2015
NRI, Net Reclassification Improvement; IDI, Integrated Discrimination ImprovementDiscrimination of model in predicting major adverse cardiovascular events (MACE).
Jiaojiao Xu (813939), Dongyu Xia (813940), Yu Xiang (261980), Lan Mi (813938), Na Zhao (112953), Zhongwei Liu (723226), Yong Zhang (5893), Zuyi Yuan (143452), Gongchang Guan (813941), Shuo Pan (583102), Xiaojun Liu (58952), Junkui Wang (813942)   +11 more
core   +1 more source

microRNAs as biomarkers of risk of major adverse cardiovascular events in atrial fibrillation

Frontiers in Cardiovascular Medicine, 2023
Atrial fibrillation is a complex and multifactorial disease. Although prophylactic anticoagulation has great benefits in avoiding comorbidities, adverse cardiovascular events still occur and thus in recent decades, many resources have been invested in the identification of useful markers in the prevention of the risk of MACE in these patients. As such,
Ascensión M. de los Reyes-García, Laura Zapata-Martínez, Sonia Águila, María L. Lozano, Constantino Martínez, Rocío González-Conejero   +5 more
openaire   +3 more sources

Impact of comorbid depression on clinical outcomes in patients with peripheral artery disease: a systematic review and meta-analysis

Frontiers in Cardiovascular Medicine
BackgroundDepression is a common comorbidity in cardiovascular disease; however, its prognostic impact in peripheral artery disease (PAD) remains uncertain.
Chuwen Chen, Lijia Wei, Jing Hu, Huanrui Hu, Bin Huang, Jichun Zhao, Wayne W. Zhang, Wayne W. Zhang, Wayne W. Zhang, Xiyang Chen   +9 more
doaj   +1 more source

Systemic lupus erythematosus and the risk of perioperative major adverse cardiovascular events [PDF]

Journal of Thrombosis and Thrombolysis, 2017
Systemic lupus erythematosus (SLE) is a significant risk factor for cardiovascular disease. The relationship between SLE and perioperative cardiovascular risks following non-cardiac surgery is uncertain. We investigated associations between a diagnosis of SLE and outcomes following major non-cardiac surgery in a large national database from the United ...
Nathaniel R, Smilowitz, Gregory, Katz, Jill P, Buyon, Robert M, Clancy, Jeffrey S, Berger   +4 more
openaire   +2 more sources

Performance of Cardiovascular Risk Prediction Models in Korean Patients With New‐Onset Rheumatoid Arthritis: National Cohort Study

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background This study aimed to compare the performance of established cardiovascular risk algorithms in Korean patients with new‐onset rheumatoid arthritis.
Jae Hyun Kim, Gaeun Lee, Jinseub Hwang, Ji‐Won Kim, Jin‐Won Kwon, Yun‐Kyoung Song   +5 more
doaj   +1 more source

The impact of diabetes mellitus on the outcome of troponin-positive patients with non-obstructive coronary arteries

International Journal of Cardiology: Heart & Vasculature
Background: Diabetes mellitus is a major cardiovascular risk factor for the development of coronary artery disease, but knowledge about the impact of diabetes mellitus on the outcome of patients with myocardial infarction with non-obstructive coronary ...
Fabienne Kreimer, Clara Schlettert, Mohammad Abumayyaleh, Ibrahim Akin, Mido Max Hijazi, Nazha Hamdani, Michael Gotzmann, Andreas Mügge, Ibrahim El-Battrawy, Assem Aweimer   +9 more
doaj   +1 more source

Impact of Baseline Glycemic Control on Residual Cardiovascular Risk in Patients With Diabetes Mellitus and High‐Risk Vascular Disease Treated With Statin Therapy

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2020
Background The contemporary impact of glycemic control on patients with diabetes mellitus at high cardiovascular risk remains unclear. We evaluated the utility of hemoglobin A1c (HbA1c) as a marker of risk on the composite end point of cardiovascular ...
Venu Menon, Anirudh Kumar, Divyang R. Patel, Julie St. John, Kathy E. Wolski, Ellen McErlean, Jeffrey S. Riesmeyer, Govinda Weerakkody, Giacomo Ruotolo, Paul C. Cremer, Stephen J. Nicholls, A. Michael Lincoff, Steven E. Nissen   +12 more
doaj   +1 more source

Associations between High Protein Intake and Cardiovascular Diseases by Age Groups: A Cohort Study

The Journal of Nutrition, Health and Aging
Background: The association between high protein intake and cardiovascular diseases (CVD) was conflicting and the role of age in this relationship was rarely studied.
Cheng Huang, Yuan Yu, Weihao Liang, Jiayong Li, Yilong Wang, Fangfei Wei, Tianyu Xu, Yu Ning, Zhe Zhen, Jia Liu, Wengen Zhu, Yugang Dong, Chen Liu, Peisen Huang   +13 more
doaj   +1 more source

Visfatin associated with major adverse cardiovascular events in patients with acute myocardial infarction

BMC Cardiovascular Disorders, 2020
Background Visfatin is an adipokine that related with the inflammation in atherosclerosis and the destabilization of atherosclerotic plaque. The aim of this study was to observe the relationship between visfatin and major adverse cardiovascular events ...
Meifan Zheng, Nan Lu, Meixia Ren, Haifeng Chen   +3 more
doaj   +1 more source